Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors exerting several functions in development and metabolism. The physiological functions of PPARdelta remain elusive. By using a CRE-Lox recombination approach, we generated an animal model for muscle-specific PPARdelta overexpression to investigate the role of PPARdelta in this tissue. Muscle-specific PPARdelta overexpression results in a profound change in fiber composition due to hyperplasia and/or shift to more oxidative fiber and, as a consequence, leads to the increase of both enzymatic activities and genes implicated in oxidative metabolism. These changes in muscle are accompanied by a reduction of body fat mass, mainly due to a large reduction of adipose cell size. Furthermore, we demonstrate that endurance exercise promotes an accumulation of PPARdelta protein in muscle of wild-type animals. Collectively, these results suggest that PPARdelta plays an important role in muscle development and adaptive response to environmental changes, such as training exercise. They strongly support the idea that activation of PPARdelta could be beneficial in prevention of metabolic disorders, such as obesity or type 2 diabetes.
Augmentation of nicotinic ␣7 receptor function is considered to be a potential therapeutic strategy aimed at ameliorating cognitive and mnemonic dysfunction in relation to debilitating pathological conditions, such as Alzheimer's disease and schizophrenia. In the present report, a novel positive allosteric modulator of the ␣7 nicotinic acetylcholine receptor (nAChR), 1-(5-chloro-2-hydroxy-phenyl)-3-(2-chloro-5-trifluoromethylphenyl)-urea (NS1738), is described. NS1738 was unable to displace or affect radioligand binding to the agonist binding site of nicotinic receptors, and it was devoid of effect when applied alone in electrophysiological paradigms. However, when applied in the presence of acetylcholine (ACh), NS1738 produced a marked increase in the current flowing through ␣7 nAChRs, as determined in both oocyte electrophysiology and patchclamp recordings from mammalian cells. NS1738 acted by increasing the peak amplitude of ACh-evoked currents at all concentrations; thus, it increased the maximal efficacy of ACh. Oocyte experiments indicated an increase in ACh potency as well. NS1738 had only marginal effects on the desensitization kinetics of ␣7 nAChRs, as determined from patch-clamp studies of both transfected cells and cultured hippocampal neurons. NS1738 was modestly brain-penetrant, and it was demonstrated to counteract a (Ϫ)-scopolamine-induced deficit in acquisition of a water-maze learning task in rats. Moreover, NS1738 improved performance in the rat social recognition test to the same extent as (Ϫ)-nicotine, demonstrating that NS1738 is capable of producing cognitive enhancement in vivo. These data support the notion that ␣7 nAChR allosteric modulation may constitute a novel pharmacological principle for the treatment of cognitive dysfunction.In clinical conditions where it is desirable to augment the function of a particular receptor type, positive allosteric modulation of the receptor in question is frequently considered preferable to classical (orthosteric) agonism. This primarily relies on the fact that actions of positive allosteric modulators are use-dependent, because only receptors activated by the endogenous ligand (agonist) are subject to modulation. Therefore, the temporospatial characteristics of endogenous receptor activation are preserved, and the function of the modulator can be considered as increasing the gain of individual receptor activation events. Agonists, in contrast, tonically activate all receptors. This will lead to a nonphysiological pattern of receptor activation, and it is also well known that prolonged agonist exposure will lead to receptor desensitization and that it affects receptor expression patterns (for review, see Quick and Lester, 2002).The cysteine-loop-containing family of ligand-gated ion channels encompasses anion-preferring receptor channels for ␥-aminobutyric acid (GABA A and GABA C receptors) and glycine as well as cation-preferring receptor channels activated by 5-hydroxytryptamine (5-hydroxytryptamine 3 receptors) and acetylcholine (nicotinic r...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.